Javaid Iqbal Sofi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Javaid Iqbal Sofi has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Henry H. Willis
RAND Corporation
1 shared publication - Junaid Nabi
Aspen Institute, Washington, DC (J.N.).
1 shared publication - Richard Staynings
Cylera, Inc., New York, NY 10005, USA
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (11) , 1734
Understanding the Risks and Benefits of Implementing AI-Enabled Remote Patient Monitoring Systems for Disease Management
Effectively managing risk is essential for fostering innovation in healthcare, especially with advancements like artificial intelligence (AI) and machine learning (ML). These technologies aim to enhance accessibility, efficiency, and equity in healthcare delivery. To assess the practical utility of AI-enabled remote patient monitoring (RPM) devices, it is crucial to identify and evaluate associated risks while distinguishing between acceptable risk, which society tolerates, and optimal risk, which balances risk reduction costs with benefits. This paper outlines how policymakers should adopt the framework of optimal risk to ensure patient safety while maximizing the advantages of these technologies.
- 17 November 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (11) , 1734
Open AccessUnderstanding the Risks and Benefits of Implementing AI-Enabled Remote Patient Monitoring Systems for Disease Management
Effectively managing risk is essential for fostering innovation in healthcare, especially with advancements like artificial intelligence (AI) and machine learning (ML). These technologies aim to enhance accessibility, efficiency, and equity in healthcare delivery. To assess the practical utility of AI-enabled remote patient monitoring (RPM) devices, it is crucial to identify and evaluate associated risks while distinguishing between acceptable risk, which society tolerates, and optimal risk, which balances risk reduction costs with benefits. This paper outlines how policymakers should adopt the framework of optimal risk to ensure patient safety while maximizing the advantages of these technologies.